AVENUE THERAPEUTICS, INC. Contracts & Agreements

71 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Placement Agent Agreement entered into by and between the Company and Aegis Capital Corp., dated January 27, 2023
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2023
Form of Restricted Stock Unit Agreement
Stock Agreements
AVENUE THERAPEUTICS, INC.
2024
Amendment to the Avenue Therapeutics, Inc. 2015 Incentive Plan
Bonus & Incentive Agreements
AVENUE THERAPEUTICS, INC.
2024
At the Market Offering Agreement, dated May 10, 2024, by and between Avenue Therapeutics, Inc. and H.C. Wainwright & Co., LLC
AVENUE THERAPEUTICS, INC.
2024
Form of Investor Inducement Letter
AVENUE THERAPEUTICS, INC.
2024
Form of New Series C Warrant (May 2024)
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2024
Form of New Series D Warrant (May 2024)
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2024
Form of Placement Agent Warrant (May 2024)
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2024
Description of Securities of Avenue Therapeutics, Inc
AVENUE THERAPEUTICS, INC.
2024
Consulting Agreement with Dr. Jay Kranzler, dated December 1, 2020
Consulting Agreements
AVENUE THERAPEUTICS, INC.
2024
Form of New Series A Warrant (January 2024)
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2024
Form of New Series B Warrant (January 2024)
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2024
Form of January 2023 Investor Inducement Letter
AVENUE THERAPEUTICS, INC.
2024
Form of November 2023 Investor Inducement Letter
AVENUE THERAPEUTICS, INC.
2024
Form of Series B Warrant (November 2023)
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2023
Form of Pre-funded Warrant (November 2023)
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2023
Warrant Agent Agreement, dated October 31, 2023 by and between Avenue Therapeutics, Inc. and VStock Transfer, LLC
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2023
Placement Agency Agreement dated October 31, 2023, by and among Avenue Therapeutics, Inc., Maxim Group LLC and Lake Street Capital Markets, LLC
Agency Agreements
AVENUE THERAPEUTICS, INC.
2023
Form of Securities Purchase Agreement, dated October 31, 2023, by and among Avenue Therapeutics, Inc. and the investors party thereto
Purchase Agreements
AVENUE THERAPEUTICS, INC.
2023
Form of Series A Warrant (November 2023)
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2023
Form of Placement Agency Agreement
Agency Agreements
AVENUE THERAPEUTICS, INC.
2023
Form of Warrant
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2023
Form of Warrant Agent Agreement
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2023
Form of Securities Purchase Agreement
Purchase Agreements
AVENUE THERAPEUTICS, INC.
2023
Form of Pre-funded Warrant
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2023
Form of Warrant Agent Agreement
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2023
Registration Rights Letter Agreement, dated September 8, 2023, by and among the Company and the purchaser parties thereto
Registration Rights Agreements
AVENUE THERAPEUTICS, INC.
2023
Form of Avenue Therapeutics, Inc. Stock Option Agreement
Stock Agreements
AVENUE THERAPEUTICS, INC.
2023
Registration Rights Agreement by and between the Company and AnnJi Pharmaceutical Co. Ltd., dated February 28, 2023
Registration Rights Agreements
AVENUE THERAPEUTICS, INC.
2023
AnnJi License Agreement by and between the Company and AnnJi Pharmaceutical Co. Ltd., dated February 28, 2023
License Agreements
AVENUE THERAPEUTICS, INC.
2023
Description of Securities of Avenue Therapeutics, Inc
AVENUE THERAPEUTICS, INC.
2023
Amendment to the Avenue Therapeutics, Inc. 2015 Incentive Plan
Bonus & Incentive Agreements
AVENUE THERAPEUTICS, INC.
2023
Form of Securities Purchase Agreement (PIPE), dated January 27, 2023, by and among the Company and the purchaser party thereto
Purchase Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2023
Form of Securities Purchase Agreement (Registered Offering), dated January 27, 2023, by and among the Company and the purchaser party thereto
Purchase Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2023
Form of Pre-Funded Warrant (Registered Offering)
Warrant Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2023
Form of PIPE Warrant (PIPE)
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2023
Form of Registration Rights Agreement, dated January 27, 2023, by and among the Company and the purchaser party thereto
Registration Rights Agreements
AVENUE THERAPEUTICS, INC.
2023
Form of Lockup Agreement
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2023
Warrant Agent Agreement, dated October 6, 2022, by and between the Company and VStock Transfer, LLC
Warrant Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2022
Form of Pre-funded Warrant
Warrant Agreements
AVENUE THERAPEUTICS, INC.
2022
Form of Warrant
Warrant Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2022
Underwriting Agreement, dated October 6, 2022, by and between the Company and Aegis Capital Corp
Underwriting Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2022
Form of Warrant Agent Agreement
Warrant Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2022
Form of Pre-funded Warrant
Warrant Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2022
Form of Warrant
Warrant Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2022
Form of Underwriting Agreement
Underwriting Agreements
AVENUE THERAPEUTICS, INC.
2022
Stock Contribution Agreement between Avenue Therapeutics, Inc. and Fortress Biotech, Inc., dated May 11, 2022
Stock Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2022
Description of Securities of Avenue Therapeutics, Inc
AVENUE THERAPEUTICS, INC.
2022
Underwriting Agreement, dated December 12, 2021, between Avenue Therapeutics, Inc. and Aegis Capital Corp., as representative of the several underwriters named therein
Underwriting Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2021
Underwriting Agreement, dated November 9, 2021, between Avenue Therapeutics, Inc. and AEGIS Capital Corp., as representative of the several underwriters named therein
Underwriting Agreements
AVENUE THERAPEUTICS, INC.
2021
Description of Securities
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2021
Facility Agreement, dated June 12, 2020, by and between Avenue Therapeutics, Inc., InvaGen Pharmaceuticals Inc., and Fortress Biotech, Inc
Facility Agreements
AVENUE THERAPEUTICS, INC.
2020
Description of Securities
AVENUE THERAPEUTICS, INC.
2020
Form of CVR Agreement
AVENUE THERAPEUTICS, INC.
2019
Registration Rights Agreement, dated February 8, 2019, by and between Avenue Therapeutics, Inc. and InvaGen Pharmaceuticals Inc
Registration Rights Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
DE
2019
Indemnification Agreement, dated as of November 12, 2018, by and between Fortress Biotech, Inc. and InvaGen Pharmaceuticals Inc
Indemnification Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
DE
2018
Stock Purchase and Merger Agreement, dated as of November 12, 2018, by and between Avenue Therapeutics, Inc., InvaGen Pharmaceuticals Inc. and Madison Pharmaceuticals Inc
Merger Agreements
AVENUE THERAPEUTICS, INC.
2018
Stockholders Agreement, dated as of November 12, 2018, by and between Avenue Therapeutics, Inc., Fortress Biotech, Inc., Dr. Lucy Lu, M.D. and InvaGen Pharmaceuticals Inc
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
DE
2018
Credit Agreement, dated as of November 12, 2018, by and between Avenue Therapeutics, Inc. and InvaGen Pharmaceuticals Inc
Credit Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
DE
2018
Guaranty, dated as of November 12, 2018, by and between Fortress Biotech, Inc. and InvaGen Pharmaceuticals Inc
Guaranty Agreements
AVENUE THERAPEUTICS, INC.
2018
Voting and Support Agreement, dated as of November 12, 2018, by and between Avenue Therapeutics, Inc., Fortress Biotech, Inc., Dr. Lucy Lu, M.D. and InvaGen Pharmaceuticals Inc
Voting Agreements
AVENUE THERAPEUTICS, INC.
2018
Waiver Agreement, dated as of November 12, 2018, by and between Avenue Therapeutics, Inc., Fortress Biotech, Inc. and InvaGen Pharmaceuticals Inc
Waiver Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
DE
2018
Restrictive Covenant Agreement, dated as of November 12, 2018, by and between Fortress Biotech, Inc. and InvaGen Pharmaceuticals Inc
AVENUE THERAPEUTICS, INC.
2018
Restrictive Covenant Agreement, dated as of November 12, 2018, by and between Dr. Lucy Lu, M.D. and InvaGen Pharmaceuticals Inc
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
DE
2018
First Amendment to Executive Employment Agreement, dated as of November 12, 2018, by and between Avenue Therapeutics, Inc. and Dr. Lucy Lu, M.D
Employment Agreements
AVENUE THERAPEUTICS, INC.
2018
Amendment No. 1 to Promissory Note from Avenue Therapeutics, Inc. to Fortress Biotech, Inc. effective as of May 15, 2017
Note Agreements
AVENUE THERAPEUTICS, INC.
2018
Amendment No. 1 to Management Services Agreement between Fortress Biotech, Inc. and Avenue Therapeutics, Inc., effective as of May 15, 2017
Management Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2018
Avenue Therapeutics, Inc. 2 Gansevoort Street, Th Floor, New York, NY 10014 www.avenuetx.com
AVENUE THERAPEUTICS, INC.
2017
[__________] Shares* Avenue Therapeutics, Inc. Common Stock FORM OF UNDERWRITING AGREEMENT
Underwriting Agreements
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
NY
2017
[__________] Shares* Avenue Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
AVENUE THERAPEUTICS, INC.
2017
Amendment 2 to Asset Transfer andLicense Agreement
AVENUE THERAPEUTICS, INC.
Pharmaceuticals
2017